Imunon Statistics
Total Valuation
Imunon has a market cap or net worth of $10.72 million. The enterprise value is -$3.36 million.
Market Cap | 10.72M |
Enterprise Value | -3.36M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, before market open.
Earnings Date | May 9, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Imunon has 9.40 million shares outstanding. The number of shares has increased by 26.63% in one year.
Shares Outstanding | 9.40M |
Shares Change (YoY) | +26.63% |
Shares Change (QoQ) | +0.28% |
Owned by Insiders (%) | 1.15% |
Owned by Institutions (%) | 4.47% |
Float | 9.37M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.80 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.47, with a Debt / Equity ratio of 0.12.
Current Ratio | 2.47 |
Quick Ratio | n/a |
Debt / Equity | 0.12 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -104.52 |
Financial Efficiency
Return on equity (ROE) is -98.00% and return on invested capital (ROIC) is -140.09%.
Return on Equity (ROE) | -98.00% |
Return on Assets (ROA) | -66.50% |
Return on Capital (ROIC) | -140.09% |
Revenue Per Employee | n/a |
Profits Per Employee | -$591,363 |
Employee Count | 33 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | -1.28M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.72% in the last 52 weeks. The beta is 2.01, so Imunon's price volatility has been higher than the market average.
Beta (1Y) | 2.01 |
52-Week Price Change | -1.72% |
50-Day Moving Average | 0.99 |
200-Day Moving Average | 0.99 |
Relative Strength Index (RSI) | 45.76 |
Average Volume (30 Days) | 221,448 |
Short Selling Information
The latest short interest is 443,265, so 4.72% of the outstanding shares have been sold short.
Short Interest | 443,265 |
Short Previous Month | 449,129 |
Short % of Shares Out | 4.72% |
Short % of Float | 4.73% |
Short Ratio (days to cover) | 1.14 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -21.03M |
Pretax Income | -20.80M |
Net Income | -19.51M |
EBITDA | -19.88M |
EBIT | -20.60M |
Earnings Per Share (EPS) | -$2.16 |
Balance Sheet
The company has $15.70 million in cash and $1.62 million in debt, giving a net cash position of $14.07 million or $1.50 per share.
Cash & Cash Equivalents | 15.70M |
Total Debt | 1.62M |
Net Cash | 14.07M |
Net Cash Per Share | $1.50 |
Equity / Book Value | 13.39M |
Book Value Per Share | 1.42 |
Working Capital | 10.85M |
Cash Flow
In the last 12 months, operating cash flow was -$19.02 million and capital expenditures -$451,759, giving a free cash flow of -$19.47 million.
Operating Cash Flow | -19.02M |
Capital Expenditures | -451,759 |
Free Cash Flow | -19.47M |
FCF Per Share | -$2.15 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Imunon does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -26.63% |
Shareholder Yield | -26.63% |
Earnings Yield | -182.11% |
FCF Yield | -181.73% |
Analyst Forecast
The average price target for Imunon is $13.00, which is 1,040.35% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $13.00 |
Price Target Difference | 1,040.35% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 1, 2022. It was a reverse split with a ratio of 1:15.
Last Split Date | Mar 1, 2022 |
Split Type | Reverse |
Split Ratio | 1:15 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |